BMC Medicine 'Under Review': What Each Status Means and When to Expect a Decision

Before your paper reaches reviewers, a BMC Medicine editor evaluates whether the submission fits the journal's scope and meets methodological standards. This is the first filter.

BMC Medicine editors are evaluating:

• does the paper report clinical or biomedical research that matters to a generalist medical audience (not just a sub-specialty community)?
• does the methodology meet the journal's standards for the study type (RCT, cohort, systematic review, etc.)?
• is the reporting checklist (CONSORT, STROBE, PRISMA, ARRIVE) complete and attached?
• are ethics approval, trial registration, and data-availability statements in order?

About 50 to 60 percent of submissions are returned at this stage, usually within 1 to 3 weeks. If you have not received a rejection by day 21, your paper has likely cleared the desk screen.

A BMC Medicine desk rejection is usually about generalist-fit or reporting-completeness, not scientific quality. The editor may recommend transferring to a discipline-specific BMC journal (BMC Cardiovascular Disorders, BMC Cancer, BMC Public Health, etc.) when scope is the issue.

The editorial office confirms files are complete: manuscript, figures, supplementary information, reporting checklist, cover letter, conflict-of-interest disclosure, ethics statement, and data-availability statement. Missing items trigger a return-for-resubmission, which delays the timeline by a week or more.

The handling editor reads the paper, evaluates generalist-clinical fit and methodological soundness, and decides whether to invite reviewers or return the paper. Most desk rejections happen in this window. If your paper is still Under Review at day 14, the editorial team has decided to proceed.

The editor invites two to three reviewers with topic-matched expertise plus one statistician for empirical work. BMC Medicine clinical-trial papers usually require three or more reviewers. Reviewer recruitment for the open peer-review model can take longer than blinded models because reviewers commit to having their name and report published.

Once reviewers accept, peer review typically takes 4 to 6 weeks. BMC Medicine reviewers know their names and reports will be published alongside the accepted paper, which produces thorough, professional reports.

After reports return, the editor synthesizes them and writes the decision letter. This typically takes 5 to 10 days. The 6-to-8-week median first-decision time captures the full pipeline from submission through editor decision.

If you have been Under Review for more than 10 weeks with no update, a polite email to the editorial office is reasonable. The delay is usually because a reviewer has not returned a report, and the editor may need a replacement.

The most common outcome after peer review. BMC Medicine rejections usually cite generalist-importance gaps ("would fit a sub-specialty BMC journal better"), reporting-checklist issues, or methodological concerns. The rejection letter includes published reviewer reports if the paper went through open review, which are valuable regardless of outcome.

BMC Medicine revisions are typically detailed and address specific reviewer concerns about reporting completeness, additional analyses, and limitations discussion. If you receive a revision request, the paper has a strong chance of eventual acceptance. Major revisions are usually due within 60 days; minor revisions within 30 days.

Possible on first round for methodologically clean and clearly clinically important work; more commonly follows one round of revision. BMC Medicine looks for generalist-clinical impact as well as scientific soundness, so even strong methodology may need one revision round to sharpen the generalist-clinical framing.

• Rejection within 1 to 5 days: Administrative issue (missing checklist, ethics statement, or required declaration) or immediate scope mismatch. Not a reflection on the science.

• Rejection within 7 to 21 days: Desk rejection. Editor concluded the paper does not meet BMC Medicine's generalist-clinical bar or fits a sister BMC journal better.

• Still Under Review after 3 weeks: Good sign. Editor has decided to proceed to peer review.

• Still Under Review after 10 weeks: Reviewer delay or replacement search. Polite inquiry is appropriate.

• Status changes to "Required Reviews Complete": Reviewers have returned reports and the editor is deliberating. Expect a decision within 1 to 2 weeks.

Through our BMC Medicine submission readiness check, we have worked with researchers at every stage of the BMC Medicine pipeline. A few insights from that experience.

The waiting itself is informative. If BMC Medicine makes no decision within 3 weeks of submission, you have almost certainly cleared the desk screen. The journal desk-rejects 50 to 60 percent within 1 to 3 weeks; silence at the 3-week mark means your paper is in reviewer recruitment or active peer review. If you are past 8 weeks, your paper is likely in the editorial-synthesis stage with reports back.

The most common anxiety we hear: "My paper has been Under Review for 10 weeks. Is that bad?" It is not. BMC Medicine's 6-to-8-week median means roughly half of papers take longer. Clinical-trial submissions and systematic reviews routinely extend to 12 to 14 weeks because reviewers verify reporting-checklist items carefully. The 10-week mark is when polite-inquiry timing starts.

One practical tip: use the waiting period to prepare your generalist-clinical framing for the discussion. BMC Medicine reviewers consistently flag papers where the discussion stays within sub-specialty boundaries rather than connecting findings to broader clinical decisions. Adding a paragraph that explicitly addresses how the finding informs a generalist-clinical decision often makes the difference between major revision and acceptance.

In our pre-submission review work with manuscripts targeting BMC Medicine, three failure patterns generate the most consistent desk rejections.

Specialty-depth framing without generalist-medicine translation. BMC Medicine editors look for findings that matter to a generalist clinical audience, not just a sub-specialty community. We observe strong-methodology submissions in cardiology, oncology, or infectious disease returned at editorial triage because the introduction never explains why a generalist clinician should care. The fix is to add a paragraph in the introduction connecting the finding to a clinical decision a non-specialist would face.

Overclaiming from observational designs. BMC Medicine reviewers carefully verify that the design supports the claim. We see observational studies whose discussion implies causal mechanisms the design cannot establish. The fix is honest framing: state the association, list plausible alternatives, and frame implications as "consistent with" rather than "demonstrates."

Missing EQUATOR reporting-checklist compliance. BMC Medicine requires the appropriate EQUATOR-network checklist (CONSORT, STROBE, PRISMA, ARRIVE) attached as supplementary material. Beyond attachment, reviewers verify the manuscript content matches the checklist. We see papers attaching a checklist but omitting the items it requires in the manuscript itself. The fix is to walk through the checklist against the manuscript and add explicit text for each item.